-Twitter Spaces
Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $325
Morgan Stanley analyst Cecilia Furlong maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $320 to $325.
Related Posts
P/E Ratio Insights for Capital One Finl
In the current market session, Capital One Finl Inc. (NYSE:COF) stock price is at $131.45, after a 1.11%…
NIO Down Over 8% On Thursday – What’s Going On?
NIO shares plummet over 8%. The company's founder eyes European expansion amid concerns over potential EU tariffs on Chinese EVs, impacting broader market sentiment.
The Beauty Health Company Q3 Adj. EPS $0.05 Beats $0.02 Estimate, Sales $88.79M Beat $80.55M Estimate
The Beauty Health Company (NASDAQ: SKIN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is a 103.07 percent increase over losses of $(1.63) per share from the same period last year.